Farther Finance Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.2K Buy
229
+10
+5% +$974 ﹤0.01% 4213
2026
Q2
$24.3K Buy
+219
New +$14.3K ﹤0.01% 3823
2026
Q1
– Sell
-135
Closed -$2.33K – 5756
2025
Q4
$2.33K Buy
135
+132
+4,400% +$2.56K ﹤0.01% 4636
2025
Q3
$67 Buy
3
+2
+200% +$76 ﹤0.01% 4854
2025
Q2
$48 Buy
+1
New +$80 ﹤0.01% 4375
2024
Q4
– Sell
-3
Closed -$295 – 4002
2024
Q3
$295 Buy
3
+1
+50% +$129 ﹤0.01% 3560
2024
Q2
$273 Buy
+2
New +$285 ﹤0.01% 3424
2024
Q1
– Sell
-1
Closed -$414 – 3588
2023
Q4
$414 Sell
1
-1
-50% -$362 ﹤0.01% 3029
2023
Q3
$817 Buy
+2
New +$904 ﹤0.01% 2131

Other funds holding AGL

Farther Finance Advisors's AGL Position: Q3 2026 in Review

Farther Finance Advisors increased its Agilon Health (AGL) stake by 4.6% in Q3 2026, buying an estimated $974 and bringing the position to 229 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4213.

Farther Finance Advisors first reported a position in AGL in Q3 2023 and has held it in 9 quarters since. The position peaked at $24.3K in Q2 2026. 6 funds tracked by Wall St. Rank hold AGL as of Q3 2026.

  • Farther Finance Advisors held 229 shares of Agilon Health worth $18.2K as of Q3 2026.
  • Farther Finance Advisors bought 10 Agilon Health shares in Q3 2026, an estimated $974.
  • Agilon Health made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4213 holding.
  • Farther Finance Advisors first reported a position in Agilon Health in Q3 2023 and has held it in 9 quarters since.
  • Farther Finance Advisors's Agilon Health position peaked at $24.3K in Q2 2026.
  • 6 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.